Summary
The product ANDRIOLOS 250 mg/ml, manufactured by Driada Medical, underwent testing to verify its authenticity and potency. The sample, identified by batch number 062435, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of Testosterone Undecanoate with a measured concentration of 250.39 mg/ml, closely matching the label claim of 250 mg/ml. This represents a 0.16% variance, demonstrating that the product is accurately dosed as per its specification.
The testing process was initiated on 6 January 2022, with the sample received on 7 January 2022, and the analysis completed on 9 January 2022. The sample was submitted and funded by Driada Medical, warranting careful scrutiny of the results. It is noted that the sample was retested twice for verification. This report is intended for educational and harm reduction purposes, helping users make informed decisions about the accuracy of anabolic steroid products.
Detailed Report
Product Overview
- Manufacturer: Driada Medical
- Product Name: ANDRIOLOS 250 mg/ml
- Active Ingredient: Testosterone Undecanoate
- Batch Number: 062435
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #16182
- Testing Ordered: 6 January 2022
- Sample Received: 7 January 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Driada Medical
- Analysis Paid For By: Driada Medical
Testing Results
- Specification: 250 mg/ml (as stated on the label)
- Measured Concentration: 250.39 mg/ml
- Accuracy: 100.16% (0.16% above the label claim)
Verification Details:
- Verification URL: https://janoshik.com/tests/16182_31JPS78X8SXB
- Originally Published: https://thinksteroids.com/community/posts/2910574/
Evaluation of Manufacturer-Funded Testing
Since this test was both submitted and paid for by the manufacturer, Driada Medical, it is important to evaluate the findings with care. Manufacturer-funded testing may involve selective sample submission or implicit pressure on the laboratory. However, the lab, Janoshik Analytical, is recognized for its transparency and history of reliable analyses. Additionally, the retesting of this sample adds a layer of verification to the results.
While the product appears to meet its specification, independent testing by a third party would further validate these findings for consumer confidence.
Conclusion
This analysis highlights the importance of laboratory testing in verifying the content and quality of anabolic steroid products. The results show that ANDRIOLOS 250 mg/ml is accurately dosed relative to its labeled specification. This report serves as a valuable resource for harm reduction and educational purposes, helping individuals make safer, evidence-based decisions regarding the use of these substances.
Disclaimer: This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
